Pyridostigmine Bromide Tablets 60 mg — Class II drug recall D-1062-2013
Terminated recall by Core Pharma Llc, reported 2013-10-02, distributed nationwide. Failed Stability Specifications: Pyridostigmine Bromide tablets, is being recalled due to an out of specificat
| Recall number | D-1062-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Core Pharma Llc, Middlesex, NJ, United States |
| Recall initiated | 2013-07-02 |
| Classified | 2013-09-20 |
| Reported by FDA | 2013-10-02 |
| Terminated | 2014-08-25 |
| Distributed | Nationwide (US) |
| Quantity | 960 bottles |
| Reason classes | specification failure |
| NDC | 64720-0128-10 |
Product
Pyridostigmine Bromide Tablets 60 mg, USP Rx Only 100 Tablets, Manufactured and Distributed by: CorePharma, LLC Middlesex, NJ 08846 NDC 64720-128-10 NDC 64720-128-10
Reason for recall
Failed Stability Specifications: Pyridostigmine Bromide tablets, is being recalled due to an out of specification test result during stablity testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1062-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.